Ian Dunn to Neoplasms
This is a "connection" page, showing publications Ian Dunn has written about Neoplasms.
Connection Strength
0.721
-
Body habitus, serum albumin, and the outcomes after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. J Neurosurg. 2017 Mar; 126(3):677-689.
Score: 0.284
-
Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019 03; 69(2):127-157.
Score: 0.086
-
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017 Oct 19; 19(11):1511-1521.
Score: 0.078
-
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015 Nov; 5(11):1164-1177.
Score: 0.068
-
Local control after fractionated stereotactic radiation therapy for brain metastases. J Neurooncol. 2014 Nov; 120(2):339-46.
Score: 0.063
-
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell. 2009 Jul 07; 16(1):21-32.
Score: 0.044
-
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell. 2009 May 29; 137(5):821-34.
Score: 0.044
-
Integrative genomic approaches to understanding cancer. Biochim Biophys Acta. 2009 Jun; 1790(6):478-84.
Score: 0.043
-
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009 Nov 05; 462(7269):108-12.
Score: 0.011